Cytogen (Korea) Odds of Future Stock Price Finishing Over 7730.0

217330 Stock  KRW 7,140  20.00  0.28%   
Cytogen's future price is the expected price of Cytogen instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cytogen performance during a given time horizon utilizing its historical volatility. Check out Cytogen Backtesting, Cytogen Valuation, Cytogen Correlation, Cytogen Hype Analysis, Cytogen Volatility, Cytogen History as well as Cytogen Performance.
  
Please specify Cytogen's target price for which you would like Cytogen odds to be computed.

Cytogen Target Price Odds to finish over 7730.0

The tendency of Cytogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over W 7,730  or more in 90 days
 7,140 90 days 7,730 
about 8.15
Based on a normal probability distribution, the odds of Cytogen to move over W 7,730  or more in 90 days from now is about 8.15 (This Cytogen probability density function shows the probability of Cytogen Stock to fall within a particular range of prices over 90 days) . Probability of Cytogen price to stay between its current price of W 7,140  and W 7,730  at the end of the 90-day period is about 48.49 .
Assuming the 90 days trading horizon Cytogen has a beta of -1.24. This suggests as returns on its benchmark rise, returns on holding Cytogen are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Cytogen is expected to outperform its benchmark. Additionally Cytogen has an alpha of 0.065, implying that it can generate a 0.065 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cytogen Price Density   
       Price  

Predictive Modules for Cytogen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cytogen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
7,1377,1407,143
Details
Intrinsic
Valuation
LowRealHigh
6,1416,1457,854
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytogen. Your research has to be compared to or analyzed against Cytogen's peers to derive any actionable benefits. When done correctly, Cytogen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cytogen.

Cytogen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cytogen is not an exception. The market had few large corrections towards the Cytogen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cytogen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cytogen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.07
β
Beta against Dow Jones-1.24
σ
Overall volatility
377.62
Ir
Information ratio -0.06

Cytogen Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cytogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cytogen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cytogen generated a negative expected return over the last 90 days
Cytogen has high historical volatility and very poor performance
The company reported the revenue of 347.85 M. Net Loss for the year was (10.87 B) with loss before overhead, payroll, taxes, and interest of (129.63 M).
Cytogen has accumulated about 30.29 B in cash with (5.23 B) of positive cash flow from operations.
Roughly 39.0% of the company shares are owned by insiders or employees

Cytogen Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cytogen Stock often depends not only on the future outlook of the current and potential Cytogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytogen's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17.5 M
Cash And Short Term Investments35.4 B
Shares Float3.2 M

Cytogen Technical Analysis

Cytogen's future price can be derived by breaking down and analyzing its technical indicators over time. Cytogen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cytogen. In general, you should focus on analyzing Cytogen Stock price patterns and their correlations with different microeconomic environments and drivers.

Cytogen Predictive Forecast Models

Cytogen's time-series forecasting models is one of many Cytogen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cytogen's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cytogen

Checking the ongoing alerts about Cytogen for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cytogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cytogen generated a negative expected return over the last 90 days
Cytogen has high historical volatility and very poor performance
The company reported the revenue of 347.85 M. Net Loss for the year was (10.87 B) with loss before overhead, payroll, taxes, and interest of (129.63 M).
Cytogen has accumulated about 30.29 B in cash with (5.23 B) of positive cash flow from operations.
Roughly 39.0% of the company shares are owned by insiders or employees

Other Information on Investing in Cytogen Stock

Cytogen financial ratios help investors to determine whether Cytogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytogen with respect to the benefits of owning Cytogen security.